Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women

Biological Psychiatry

Volumn 51, Issue 8, 2002, Pages 677-682

  Yaffe, Kristine ^a,b,c   Lui, Li Yung ^b   Grady, Deborah ^b,c   Stone, Katie ^b   Morin, Philip ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Axys Pharmaceuticals Inc   (United States)

Author keywords

Cognition; Dementia; Elderly women; Estrogen; Polymorphisms

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; PROTEIN SUBUNIT;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLOW UP; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DEMENTIA; EDUCATIONAL STATUS; ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MENTAL STATUS SCHEDULE; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; RISK FACTORS;

EID: 0037090561     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01289-6     Document Type: Article

References (29)

1. Estrogen receptor alpha gene polymorphisms and bone mineral density: Haplotype analysis in women from the United Kingdom
2. Screening for ESR mutations in breast and ovarian cancer patients
3. Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease
4. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group
5. Association of VDR and estrogen receptor genotypes with bone mass in postmenopausal Caucasian women: Different conclusions with different analyses and the implications
6. Estimated prevalence of Alzheimer's disease in the United States
7. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis
8. "Mini-mental state:" A practical method for grading the cognitive state of patients for the clinician
9. Association of estrogen receptor gene polymorphisms with endometriosis
10. Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women
11. Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia
12. Cerebrovascular disease, the apolipoprotein E4 allele, and cognitive decline in a community-based study of elderly men
13. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore longitudinal study of aging
14. Association of bone mineral density with polymorphism of the estrogen receptor gene
15. Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEM pooled analyses
16. Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer's disease
17. Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women
18. Clinical review 108: The molecular and neuroanatomical basis for estrogen effects in the central nervous system
19. High-throughput single nucleotide polymorphism genotyping by fluorescent 5′ exonuclease assay
20. Estrogen replacement therapy and longitudinal decline in visual memory: A possible protective effect?
21. Geriatric depression scale: Recent evidence and development of a shorter version
22. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women
23. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system
24. Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway
25. Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: Implications for Alzheimer's disease
26. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
27. Estrogen use, APOE, and cognitive decline: Evidence of gene-environment interaction
28. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations
29. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood